We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
-2.76%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$5.27B
AUM Growth
+$804M
(+18%)
Cap. Flow
+$1.19B
Cap. Flow
% of AUM
22.6%
Top 10 Holdings %
Top 10 Hldgs %
6.53%
Holding
2,150
New
668
Increased
458
Reduced
360
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$49.8M |
| 2 |
DoorDash
DASH
|
+$40.6M |
| 3 |
Eli Lilly
LLY
|
+$33.4M |
| 4 |
Capital One
COF
|
+$33.1M |
| 5 |
Emerson Electric
EMR
|
+$31.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$116M |
| 2 |
Broadcom
AVGO
|
+$111M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$32.8M |
| 4 |
Rivian
RIVN
|
+$27.2M |
| 5 |
Petrobras
PBR
|
+$25.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.13% |
| 2 | Financials | 14.83% |
| 3 | Industrials | 13.9% |
| 4 | Healthcare | 11.78% |
| 5 | Consumer Discretionary | 11.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GENB
1426
Generate Biomedicines
GENB
$1.75B
| $230K | ﹤0.01% |
+18,362
| New | +$224K |
|
1427
Vodafone
VOD
$36.4B
| $225K | ﹤0.01% |
14,974
-18,526
| -55% | -$271K |
|
1428
FIVE9
FIVN
$1.96B
| $221K | ﹤0.01% |
14,574
-88,904
| -86% | -$1.55M |
|
1429
LCI Industries
LCII
$2.52B
| $220K | ﹤0.01% |
+1,791
| New | +$245K |
|
1430
RH
RH
$3.4B
| $217K | ﹤0.01% |
1,554
-1,729
| -53% | -$315K |
|
1431
iShares International Select Dividend ETF
IDV
$8.24B
| $217K | ﹤0.01% |
+5,105
| New | +$215K |
|
1432
Latham Group
SWIM
$661M
| $217K | ﹤0.01% |
40,424
-753
| -2% | -$4.8K |
|
1433
Insight Enterprises
NSIT
$3.71B
| $217K | ﹤0.01% |
+3,235
| New | +$264K |
|
1434
Apple Hospitality REIT
APLE
$3.98B
| $214K | ﹤0.01% |
+18,592
| New | +$225K |
|
1435
Appian
APPN
$1.88B
| $213K | ﹤0.01% |
8,826
-59,362
| -87% | -$1.61M |
|
1436
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.29B
| $212K | ﹤0.01% |
1,773
| – | – |
|
1437
Westamerica Bancorp
WABC
$1.38B
| $209K | ﹤0.01% |
4,002
-46,524
| -92% | -$2.36M |
|
1438
Vanguard Real Estate ETF
VNQ
$39.8B
| $208K | ﹤0.01% |
2,350
-2,780
| -54% | -$255K |
|
|
DMRA
1439
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.81B
| $205K | ﹤0.01% |
+7,921
| New | +$204K |
|
1440
Dentsply Sirona
XRAY
$2.61B
| $195K | ﹤0.01% |
16,798
-162,285
| -91% | -$2.02M |
|
|
AIV
1441
Aimco
AIV
$377M
| $191K | ﹤0.01% |
46,889
-766,070
| -94% | -$4.01M |
|
1442
Marqeta
MQ
$1.85B
| $185K | ﹤0.01% |
11,343
-13,116
| -54% | -$221K |
|
1443
Tronox
TROX
$973M
| $180K | ﹤0.01% |
18,453
-87,026
| -83% | -$603K |
|
1444
Sotera Health
SHC
$4.92B
| $178K | ﹤0.01% |
12,393
-206,062
| -94% | -$3.42M |
|
|
VLRS
1445
Controladora Vuela Compania de Aviacion
VLRS
$898M
| $177K | ﹤0.01% |
+24,474
| New | +$214K |
|
1446
Relay Therapeutics
RLAY
$4.06B
| $174K | ﹤0.01% |
+17,516
| New | +$157K |
|
1447
Gilat Satellite Networks
GILT
$831M
| $169K | ﹤0.01% |
+11,260
| New | +$187K |
|
1448
Mativ Holdings
MATV
$455M
| $153K | ﹤0.01% |
17,608
-56,084
| -76% | -$643K |
|
1449
Payoneer
PAYO
$2.41B
| $150K | ﹤0.01% |
31,091
-81,357
| -72% | -$429K |
|
1450
ODDITY Tech
ODD
$758M
| $147K | ﹤0.01% |
10,966
-30,407
| -73% | -$762K |
|
Similar funds
HSA
O
LIM
LFG
JIM
CTC
NL
BPWM
Y-Intercept (HK)'s Q1 2026 Portfolio in Review
As of Q1 2026, Y-Intercept (HK) held 2,150 positions worth $5.27B, up 18% from $4.47B the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.
Y-Intercept (HK) deployed $1.19B of net new capital in Q1 2026, opening 668 new positions and adding to 458 existing holdings. Its largest new stake was Micron Technology: 127,057 shares worth $42.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Charles Schwab, an estimated $32.8M trimmed.
- Y-Intercept (HK)'s largest Q1 2026 buy was Micron Technology: 127,057 shares worth $42.9M.
- Y-Intercept (HK) added most to Boston Scientific in Q1 2026, an estimated $31M increase.
- Y-Intercept (HK)'s biggest Q1 2026 reduction was Charles Schwab, cutting an estimated $32.8M.
- Y-Intercept (HK) fully exited NVIDIA in Q1 2026, selling an estimated $116M.
- Y-Intercept (HK)'s ten largest holdings make up 6.5% of its $5.27B portfolio in Q1 2026.
- Y-Intercept (HK) opened 668 new positions and closed 654 in Q1 2026.
- Y-Intercept (HK)'s portfolio value rose 18% quarter-over-quarter to $5.27B.
Based on Y-Intercept (HK)'s 13F filing for Q1 2026, filed 27 Apr 2026.